Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug-Drug Interaction Study of KL0011034 and Alfentanil in Chronic Pain
NCT07751094Phase 1Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Jul 2026
- Primary completion
- Jul 2027
01
Overview
Phase 1, randomised, open-label trial of KL0011034 in chronic pain (6 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve From Time Zero to Last Quantifiable Concentration and 1 more. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
KL0011034
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT07751094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07751094.